Phase 2 study of pre-excision single-dose intraoperative radiation therapy for early-stage breast cancers: Six-year update with application of the ASTRO accelerated partial breast irradiation consensus statement criteria

Cancer

Volumn 119, Issue 9, 2013, Pages 1736-1743

  Vanderwalde, Noam A ^a,b   Jones, Ellen L ^a,b   Kimple, Randall J ^c   Moore, Dominic T ^b   Klauber Demore, Nancy ^a,b   Sartor, Carolyn I ^a,b   Ollila, David W ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

breast neoplasm; intraoperative procedure; radiation therapy; radiotherapy dosage; surgery

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; CANCER SIZE; CANCER SURVIVAL; CONTROLLED STUDY; EARLY CANCER; ECHOMAMMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; INTRAOPERATIVE RADIOTHERAPY; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RADIATION DOSE; TRIPLE NEGATIVE BREAST CANCER;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INTRAOPERATIVE CARE; MIDDLE AGED;

EID: 84876665343     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27915     Document Type: Article

References (26)

1. Whelan TJ, Pignol JP, Levine MN, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010; 362: 513-520.
2. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002; 347: 1233-1241.
3. Bartelink H, Horiot JC, Poortmans PM, et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol. 2007; 25: 3259-3265.
4. Lazovich DA, White E, Thomas DB, Moe RE,. Underutilization of breast-conserving surgery and radiation therapy among women with stage I or II breast cancer. JAMA. 1991; 266: 3433-3438.
5. Athas WF, Adams-Cameron M, Hunt WC, Amir-Fazli A, Key CR,. Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst. 2000; 92: 269-271.
6. Gujral DM, Sumo G, Owen JR, et al. Ipsilateral breast tumor relapse: local recurrence versus new primary tumor and the effect of whole-breast radiotherapy on the rate of new primaries. Int J Radiat Oncol Biol Phys. 2011; 79: 19-25.
7. Shah C, Antonucci JV, Wilkinson JB, et al. Twelve-year clinical outcomes and patterns of failure with accelerated partial breast irradiation versus whole-breast irradiation: results of a matched-pair analysis. Radiother Oncol. 2011; 100: 210-214.
8. Polgár C, Fodor J, Major T, et al. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma-5-year results of a randomized trial. Int J Radiat Oncol Biol Phys. 2007; 69: 694-702.
9. Dobelbower RR, Merrick HW, Eltaki A, Bronn DG,. Intraoperative electron beam therapy and external photon beam therapy with lumpectomy as primary treatment for early breast cancer. Ann Radiol (Paris). 1989; 32: 497-501.
10. Vaidya JS, Baum M, Tobias JS, et al. Targeted intra-operative radiotherapy (Targit): an innovative method of treatment for early breast cancer. Ann Oncol. 2001; 12: 1075-1080.
11. Veronesi U, Orecchia R, Luini A, et al. Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery: experience with 590 cases. Ann Surg. 2005; 242: 101-106.
12. Sacchini V, Beal K, Goldberg J, Montgomery L, Port E, McCormick B,. Study of quadrant high-dose intraoperative radiation therapy for early-stage breast cancer. Br J Surg. 2008; 95: 1105-1110.
13. Maluta S, Dall'Oglio S, Marciai N, et al. Accelerated partial breast irradiation using only intraoperative electron radiation therapy in early stage breast cancer. Int J Radiat Oncol Biol Phys. 2012; 84: e145-e152
14. Lemanski C, Azria D, Gourgon-Bourgade S, et al. Intraoperative radiotherapy in early-stage breast cancer: results of the montpellier phase II trial. Int J Radiat Oncol Biol Phys. 2010; 76: 698-703.
15. Kimple RJ, Klauber-DeMore N, Kuzmiak CM, et al. Cosmetic outcomes for accelerated partial breast irradiation before surgical excision of early-stage breast cancer using single-dose intraoperative radiotherapy. Int J Radiat Oncol Biol Phys. 2011; 79: 400-407.
16. Kimple RJ, Klauber-Demore N, Kuzmiak CM, et al. Local control following single-dose intraoperative radiotherapy prior to surgical excision of early-stage breast cancer. Ann Surg Oncol. 2011; 18: 939-945.
17. Ollila DW, Klauber-DeMore N, Tesche LJ, et al. Feasibility of breast preserving therapy with single fraction in situ radiotherapy delivered intraoperatively. Ann Surg Oncol. 2007; 14: 660-669.
18. Smith BD, Arthur DW, Buchholz TA, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys. 2009; 74: 987-1001.
19. Holland R, Veling SH, Mravunac M, et al. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer. 1985; 56: 979-990.
20. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 366: 2087-2106.
21. Veronesi U, Orecchia R, Luini A, et al. Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons. Breast Cancer Res Treat. 2010; 124: 141-151.
22. Leonardi MC, Maisonneuve P, Mastropasqua MG, et al. How do the ASTRO consensus statement guidelines for the application of accelerated partial breast irradiation fit intraoperative radiotherapy? A retrospective analysis of patients treated at the European Institute of Oncology. Int J Radiat Oncol Biol Phys. 2012; 83: 806-813.
23. Vaidya JS, Joseph DJ, Tobias JS, et al. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet. 2010; 376: 91-102.
24. Beal K, Sacchini V, Zelefsky M, Rogers KH, McCormick B,. Five year update on intraoperative radiation therapy for breast cancer. ASTRO 2011: 53rd Annual Meeting of the American Society for Radiation Oncology; October 2-6, 2011; Miami Beach, Florida. Int J Radiat Oncol Biol Phys. 2011; 81 (2 suppl): s241-s242.
25. Bartelink H, Bourgier C, Elkhuizen P,. Has partial breast irradiation by IORT or brachytherapy been prematurely introduced into the clinic? Radiother Oncol. 2012; 104: 139-142.
26. Kirkpatrick JP, Meyer JJ, Marks LB,. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Semin Radiat Oncol. 2008; 18: 240-243.